InsidersTradesSigma
Follow the Abliva AB stock price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares trade on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Abliva AB has logged 1 public disclosures. The latest transaction was filed on 7 March 2025 (Sale). Among the most active insiders: Eskil Elmér. All data is openly available.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€23,549
1 ops.
Sell Volume
15Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 March 2025
Declarations1 total
574,978 shares@ €0.041100.0% of flowAktieISIN SE0002575340FI:A003M247-1
1 of 1 declaration
About Abliva AB
Abliva AB is a Swedish biopharmaceutical company focused on developing treatments for mitochondrial diseases. It is listed on the Stockholm Stock Exchange (XSTO).